WBA241220P9000
- 0.01
- 0.000.00%
Walgreens Boots Alliance Newsroom
Walgreens Boots Alliance Is Maintained at Hold by Truist Securities
Truist Financial Initiates Walgreens Boots Alliance(WBA.US) With Hold Rating, Announces Target Price $13
Walgreens Boots Alliance Is Maintained at Sector Perform by RBC Capital
RBC Capital Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating, Raises Target Price to $12
RBC Raises Price Target on Walgreens Boots Alliance to $12 From $9, Keeps Sector Perform Rating
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Quanterix (QTRX) and Walgreens Boots Alliance (WBA)
A Quick Look at Today's Ratings for Walgreens Boots Alliance(WBA.US), With a Forecast Between $7 to $15
Jefferies Adjusts Walgreens Boots Alliance Price Target to $11 From $9
TD Cowen Adjusts Price Target on Walgreens Boots Alliance to $15 From $14
Walgreens Boots Alliance Is Maintained at Underperform by B of A Securities
Walgreens Boots Alliance Price Target Raised to $8.50/Share From $7.50 by B of A Securities
Walgreens Boots Alliance Analyst Ratings
Truist Financial Sticks to Its Hold Rating for Walgreens Boots Alliance (WBA)
BofA Securities Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Raises Target Price to $8.5
Deutsche Bank Adjusts Walgreens Boots Alliance Price Target to $11 From $10, Maintains Hold Rating
Challenges in Profitability and Financial Flexibility Lead to Sell Rating on Walgreens Boots Alliance
Morgan Stanley Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Raises Target Price to $15
Morgan Stanley Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Evercore Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating, Cuts Target Price to $12